Literature DB >> 27728768

In-Depth Cerebrospinal Fluid Quantitative Proteome and Deglycoproteome Analysis: Presenting a Comprehensive Picture of Pathways and Processes Affected by Multiple Sclerosis.

Ann Cathrine Kroksveen1,2, Astrid Guldbrandsen1,2, Marc Vaudel1,2, Ragnhild Reehorst Lereim1,2, Harald Barsnes1,2, Kjell-Morten Myhr1,2, Øivind Torkildsen1,2, Frode S Berven1,2.   

Abstract

In the current study, we conducted a quantitative in-depth proteome and deglycoproteome analysis of cerebrospinal fluid (CSF) from relapsing-remitting multiple sclerosis (RRMS) and neurological controls using mass spectrometry and pathway analysis. More than 2000 proteins and 1700 deglycopeptides were quantified, with 484 proteins and 180 deglycopeptides significantly changed between pools of RRMS and pools of controls. Approximately 300 of the significantly changed proteins were assigned to various biological processes including inflammation, extracellular matrix organization, cell adhesion, immune response, and neuron development. Ninety-six significantly changed deglycopeptides mapped to proteins that were not found changed in the global protein study. In addition, four mapped to the proteins oligo-myelin glycoprotein and noelin, which were found oppositely changed in the global study. Both are ligands to the nogo receptor, and the glycosylation of these proteins appears to be affected by RRMS. Our study gives the most extensive overview of the RRMS affected processes observed from the CSF proteome to date, and the list of differential proteins will have great value for selection of biomarker candidates for further verification.

Entities:  

Keywords:  TMT; biomarkers; cerebrospinal fluid; glycosylation; immune system; inflammation; multiple sclerosis; neuron development; protein networks

Mesh:

Substances:

Year:  2016        PMID: 27728768     DOI: 10.1021/acs.jproteome.6b00659

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  12 in total

Review 1.  Proteomic Approaches to Decipher Mechanisms Underlying Pathogenesis in Multiple Sclerosis Patients.

Authors:  Vaibhav Singh; Ajai Tripathi; Ranjan Dutta
Journal:  Proteomics       Date:  2019-06-21       Impact factor: 3.984

2.  Recent advances in mass spectrometry (MS)-based glycoproteomics in complex biological samples.

Authors:  Zhengwei Chen; Junfeng Huang; Lingjun Li
Journal:  Trends Analyt Chem       Date:  2018-10-15       Impact factor: 12.296

3.  Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis.

Authors:  Astrid Guldbrandsen; Ragnhild Reehorst Lereim; Mari Jacobsen; Hilde Garberg; Ann Cathrine Kroksveen; Harald Barsnes; Frode S Berven
Journal:  Clin Proteomics       Date:  2020-09-18       Impact factor: 3.988

4.  Mapping human N-linked glycoproteins and glycosylation sites using mass spectrometry.

Authors:  Liuyi Dang; Li Jia; Yuan Zhi; Pengfei Li; Ting Zhao; Bojing Zhu; Rongxia Lan; Yingwei Hu; Hui Zhang; Shisheng Sun
Journal:  Trends Analyt Chem       Date:  2019-02-13       Impact factor: 12.296

5.  Orthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes.

Authors:  Nellie A Martin; Arkadiusz Nawrocki; Viktor Molnar; Maria L Elkjaer; Eva K Thygesen; Miklos Palkovits; Peter Acs; Tobias Sejbaek; Helle H Nielsen; Zoltan Hegedus; Finn Sellebjerg; Tihamer Molnar; Eudes G V Barbosa; Nicolas Alcaraz; Ferenc Gallyas; Asa F Svenningsen; Jan Baumbach; Hans Lassmann; Martin R Larsen; Zsolt Illes
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

6.  ProteomicsDB: toward a FAIR open-source resource for life-science research.

Authors:  Ludwig Lautenbacher; Patroklos Samaras; Julian Muller; Andreas Grafberger; Marwin Shraideh; Johannes Rank; Simon T Fuchs; Tobias K Schmidt; Matthew The; Christian Dallago; Holger Wittges; Burkhard Rost; Helmut Krcmar; Bernhard Kuster; Mathias Wilhelm
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

7.  Posttranslational modifications of proteins are key features in the identification of CSF biomarkers of multiple sclerosis.

Authors:  Ivan L Salazar; Ana S T Lourenço; Bruno Manadas; Inês Baldeiras; Cláudia Ferreira; Anabela Claro Teixeira; Vera M Mendes; Ana Margarida Novo; Rita Machado; Sónia Batista; Maria do Carmo Macário; Mário Grãos; Lívia Sousa; Maria João Saraiva; Alberto A C C Pais; Carlos B Duarte
Journal:  J Neuroinflammation       Date:  2022-02-08       Impact factor: 8.322

8.  Pilot proteomic analysis of cerebrospinal fluid in Alzheimer's disease.

Authors:  Justin McKetney; Daniel J Panyard; Sterling C Johnson; Cynthia M Carlsson; Corinne D Engelman; Joshua J Coon
Journal:  Proteomics Clin Appl       Date:  2021-04-26       Impact factor: 3.494

9.  Comparison of plasma and cerebrospinal fluid proteomes identifies gene products guiding adult neurogenesis and neural differentiation in birds.

Authors:  Eleni Voukali; Nithya Kuttiyarthu Veetil; Pavel Němec; Pavel Stopka; Michal Vinkler
Journal:  Sci Rep       Date:  2021-03-05       Impact factor: 4.379

Review 10.  Recent Advances in Analytical Approaches for Glycan and Glycopeptide Quantitation.

Authors:  Daniel G Delafield; Lingjun Li
Journal:  Mol Cell Proteomics       Date:  2021-02-20       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.